Warning: The NCBI web site requires JavaScript to function. more...
New York City HIV superbug: fear or fear not?
Smith SM.
Retrovirology. 2005 Mar 2;2:14.
Related citations
Aggressive HIV-1?
Berkhout B, de Ronde A, van der Hoek L.
Retrovirology. 2005 Feb 28;2:13.
New York City case of multidrug-resistant, rapid AIDS progression baffling. Health officials continue investigation.
[No authors listed]
AIDS Alert. 2005 Apr;20(4):37, 39-40.
Investigation of a new diagnosis of multidrug-resistant, dual-tropic HIV-1 infection--New York City, 2005.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2006 Jul 28;55(29):793-6.
New York draws fire over case of drug-resistant HIV.
Check E.
Nature. 2005 Feb 24;433(7028):788. No abstract available.
Multidrug resistant HIV and rapid progression of disease reported from New York.
Pillay D, Parry J.
Euro Surveill. 2005 Feb 24;10(2):E050224.2. No abstract available.
The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.
Blick G, Kagan RM, Coakley E, Petropoulos C, Maroldo L, Greiger-Zanlungo P, Gretz S, Garton T.
J Infect Dis. 2007 May 1;195(9):1250-9. Epub 2007 Mar 21.
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.
Markowitz M, Mohri H, Mehandru S, Shet A, Berry L, Kalyanaraman R, Kim A, Chung C, Jean-Pierre P, Horowitz A, La Mar M, Wrin T, Parkin N, Poles M, Petropoulos C, Mullen M, Boden D, Ho DD.
Lancet. 2005 Mar 19-25;365(9464):1031-8.
New resistant strain of HIV worries health officials.
AIDS Policy Law. 2005 Feb 25;20(4):5. No abstract available.
New superbug or tempest in a teapot?
Brower V.
EMBO Rep. 2005 Jun;6(6):502-4. No abstract available.
Highly resistant HIV: if not a super strain, at least a wake-up call.
Taege AJ, Armstrong WS.
Cleve Clin J Med. 2005 Apr;72(4):285-6. No abstract available.
Growing number of drug resistant strains dominates at retroviruses conference. Drug resistance is an 800-pound gorilla.
AIDS Alert. 2005 May;20(5):49, 51-3.
[Reactions to the New York "supervirus". A challenge in primary resistance].
Paukstadt W.
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:86. German. No abstract available.
Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches.
Bernstein KT, Liu KL, Begier EM, Koblin B, Karpati A, Murrill C.
Arch Intern Med. 2008 Jul 14;168(13):1458-64.
Back to the future? Diabetes, HIV, and the boundaries of public health.
Fairchild AL, Alkon A.
J Health Polit Policy Law. 2007 Aug;32(4):561-93.
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.
Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV.
Ann Intern Med. 2006 Sep 19;145(6):397-406.
Time trends for HIV-1 antiretroviral resistance among antiretroviral-experienced and naive pregnant women in New York City during 1991 to early 2001.
Welles SL, Bauer GR, LaRussa PS, Colgrove RC, Pitt J.
J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):329-35.
Profile of drug-resistant case in New York.
AIDS Patient Care STDS. 2005 May;19(5):348. No abstract available.
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.
AIDS. 2008 Oct 18;22(16):2187-98.
Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience.
Shet A, Berry L, Mohri H, Mehandru S, Chung C, Kim A, Jean-Pierre P, Hogan C, Simon V, Boden D, Markowitz M.
J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):439-46.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on